Company intelligence / Profile preview

Bellevue Asset Management

Ownership: Private
Employees: ~90
Development stage: Other

Overview

Bellevue Asset Management is a leading European asset manager specializing in healthcare and biotech investments. Through its funds—such as BB Biotech and the Medtech & Services Fund—it provides investors access to innovative public and private life science companies globally. The firm is recognized for its deep sector expertise and active management approach focused on structural growth trends within healthcare.

Therapeutic areas: OncologyPulmonologyMetabolic DisordersImmunologyRare DiseasesInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyGene therapyMedical devices
Industry: Investors

Partnerships

No specific major pharma partnerships disclosed—acts primarily as an investor.

Beyond the preview

Go deeper on Bellevue Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bellevue Asset Management.

Explore the full profile